» Articles » PMID: 24678453

Efficient Designer Nuclease-based Homologous Recombination Enables Direct PCR Screening for Footprintless Targeted Human Pluripotent Stem cells

Overview
Publisher Cell Press
Specialty Cell Biology
Date 2014 Mar 29
PMID 24678453
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic engineering of human induced pluripotent stem cells (hiPSCs) via customized designer nucleases has been shown to be significantly more efficient than conventional gene targeting, but still typically depends on the introduction of additional genetic selection elements. In our study, we demonstrate the efficient nonviral and selection-independent gene targeting in human pluripotent stem cells (hPSCs). Our high efficiencies of up to 1.6% of gene-targeted hiPSCs, accompanied by a low background of randomly inserted transgenes, eliminated the need for antibiotic or fluorescence-activated cell sorting selection, and allowed the use of short donor oligonucleotides for footprintless gene editing. Gene-targeted hiPSC clones were established simply by direct PCR screening. This optimized approach allows targeted transgene integration into safe harbor sites for more predictable and robust expression and enables the straightforward generation of disease-corrected, patient-derived iPSC lines for research purposes and, ultimately, for future clinical applications.

Citing Articles

Unlocking the Future: Pluripotent Stem Cell-Based Lung Repair.

Goecke T, Ius F, Ruhparwar A, Martin U Cells. 2024; 13(7.

PMID: 38607074 PMC: 11012168. DOI: 10.3390/cells13070635.


Targeted biallelic integration of an inducible Caspase 9 suicide gene in iPSCs for safer therapies.

Wunderlich S, Haase A, Merkert S, Jahn K, Deest M, Frieling H Mol Ther Methods Clin Dev. 2022; 26:84-94.

PMID: 35795779 PMC: 9234009. DOI: 10.1016/j.omtm.2022.05.011.


Towards Biohybrid Lung: Induced Pluripotent Stem Cell Derived Endothelial Cells as Clinically Relevant Cell Source for Biologization.

Pflaum M, Dahlmann J, Engels L, Naghilouy-Hidaji H, Adam D, Zollner J Micromachines (Basel). 2021; 12(8).

PMID: 34442603 PMC: 8401467. DOI: 10.3390/mi12080981.


Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants.

Dahlke J, Schott J, Vollmer Barbosa P, Klatt D, Selich A, Lachmann N J Pers Med. 2021; 11(6).

PMID: 34204193 PMC: 8234706. DOI: 10.3390/jpm11060565.


Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages.

Hoffmann D, Sens J, Brennig S, Brand D, Philipp F, Vollmer Barbosa P J Pers Med. 2021; 11(3).

PMID: 33804706 PMC: 8003874. DOI: 10.3390/jpm11030221.


References
1.
Zou J, Maeder M, Mali P, Pruett-Miller S, Thibodeau-Beganny S, Chou B . Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell. 2009; 5(1):97-110. PMC: 2720132. DOI: 10.1016/j.stem.2009.05.023. View

2.
Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver R . Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol. 2009; 27(9):851-7. PMC: 4142824. DOI: 10.1038/nbt.1562. View

3.
Hartung S, Schwanke K, Haase A, David R, Franz W, Martin U . Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. Stem Cells Dev. 2012; 22(7):1112-25. PMC: 3608024. DOI: 10.1089/scd.2012.0351. View

4.
Yusa K, Rashid S, Strick-Marchand H, Varela I, Liu P, Paschon D . Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature. 2011; 478(7369):391-4. PMC: 3198846. DOI: 10.1038/nature10424. View

5.
Elliott D, Braam S, Koutsis K, Ng E, Jenny R, Lagerqvist E . NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods. 2011; 8(12):1037-40. DOI: 10.1038/nmeth.1740. View